Expression of the HPV E7 oncoprotein mimics but does not evoke a p53- dependent cellular DNA damage response pathway

Virology

Volumn 258, Issue 2, 1999, Pages 406-414

  Jones, D Leanne ^a   Thompson, David A ^a   Suh Bürgmann, Elizabeth ^a   Grace, Miranda ^a   Münger, Karl ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ONCOPROTEIN; PROTEIN P21; PROTEIN P53; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPOVAVIRIDAE;

EID: 0033526505     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9733     Document Type: Article

References (63)

1. Alani R. M., Hasskarl J., Munger K. Alterations in cyclin-dependent kinase 2 function during differentiation of primary human keratinocytes. Mol. Carcinog. 23:1998;226-233.
2. Almasan A., Yin Y. X., Kelly R. E., Lee E.-Y.H.-P., Bradley A., Li W. W., Bertino J. R., Wahl G. M. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA. 92:1995;5436-5440.
3. An B., Dou Q. P. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res. 56:1996;438-442.
4. Bates S., Phillips A. C., Clark P. A., Stott F., Peters G., Ludwig R. L., Vousden K. H. p14ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
5. Berezutskaya E., Bagchi S. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome. J. Biol. Chem. 272:1997;30135-30140.
6. Boyer S. N., Wazer D. E., Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:1996;4620-4624.
7. Cayrol C., Ducommun B. Interaction with cyclin-dependent kinases and PCNA modulates proteasome- dependent degradation of p21. Oncogene. 17:1998;2437-2444.
8. Chellappan S., Kraus V. B., Kroger B., Münger K., Howley P. M., Phelps W. C., Nevins J. R. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA. 89:1992;4549-4553.
9. Chiou S. K., White E. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71:1997;3515-3525.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Cryns V., Yuan J. Proteases to die for. Genes Dev. 12:1998;1551-1570.
12. Davies R. C., Vousden K. H. Functional analysis of human papillomavirus type 16 E7 by complementation with adenovirus E1A mutants. J. Gen. Virol. 73:1992;2135-2139.
13. de Stanchina E., McCurrach M. E., Zindy F., Shieh S. Y., Ferbeyre G., Samuelson A. V., Prives C., Roussel M. F., Sherr C. J., Lowe S. W. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12:1998;2434-2442.
14. Demers G. W., Foster S. A., Halbert C. L., Galloway D. A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA. 91:1994b;4382-4386.
15. Demers G. W., Halbert C. L., Galloway D. A. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology. 198:1994a;169-174.
16. Deng C. X., Zhang P. M., Harper J. W., Elledge S. J., Leder P. Mice lacking p21(CIP1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
17. Dyson N., Guida P., Münger K., Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:1992;6893-6902.
18. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
19. El-Deiry W. S., Harper J. W., Oconnor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y. S., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. Waf1/Cip1 is induced in p53-mediated G(1) arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
20. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
21. Funk J. O., Waga S., Harry J. B., Espling E., Stillman B., Galloway D. A. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:1997;2090-2100.
22. Gottlieb E., Haffner R., von Ruden T., Wagner E. F., Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13:1994;1368-1374.
23. Gu W., Roeder R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
24. Haaskogan D. A., Kogan S. C., Levi D., Dazin P., Tang A., Fung Y. K. T., Israel M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
25. Halbert C. L., Demers W., Galloway D. A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:1991;473-478.
26. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
27. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
28. Haupt Y., Rowan S., Oren M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene. 10:1995;1563-1571.
29. Howley P. M. Papillomavirinae: The viruses and their replication. Fundamental Virology. 1996;Lippincott-Raven, Philadelphia. p. 947-978.
30. Janicke R. U., Walker P. A., Lin X. Y., Porter A. G. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:1996;6969-6978.
31. Jian Y., Schmidt-Grimminger D. C., Chien W. M., Wu X., Broker T. R., Chow L. T. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes. Oncogene. 17:1998;2027-2038.
32. Cip1-mediated inhibition of cdk2. Genes Dev. 11:1997a;2101-2111.
33. Jones D. L., Münger K. Interactions of the human papillomavirus E7 protein with cell cycle regulators. Semin. Cancer Biol. 7:1996;327-337.
34. Jones D. L., Münger K. Analysis of the p53- mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71:1997;2905-2912.
35. Jones D. L., Thompson D. A., Münger K. Destabilization of the RB tumor suppressor and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 239:1997b;97-107.
36. Kubbutat M. H., Jones S. N., Vousden K. H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
37. Levine A. J. p53, cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
38. Macleod K. F., Hu Y., Jacks T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15:1996;6178-6188.
39. Macleod K. F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935-944.
40. Maki C. G., Howley P. M. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell Biol. 17:1997;355-363.
41. Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:1989;980-982.
42. Morgenstern J. P., Land H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:1990;3587-3596.
43. Nichols W. W., Murphy D. G., Cristofalo V. J., Toji L. H., Greene A. E., Dwight S. A. Characterization of a new human diploid cell strain, IMR-90. Science. 196:1977;60-63.
44. Pagano M., Dürst M., Joswig S., Draetta G., Jansen-Dürr P. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene. 7:1992;1681-1686.
45. Samuelson A. V., Lowe S. W. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl. Acad. Sci. USA. 94:1997;12094-12099.
46. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
47. Shan B., Chang C. Y., Jones D., Lee W. H. The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol. Cell Biol. 14:1994;299-309.
48. Shieh S. Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 91:1997;325-334.
49. Slebos R. J. C., Lee M. H., Plunkett B. S., Kessis T. D., Williams B. O., Jacks T., Hedrick L., Kastan M. B., Cho K. R. p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA. 91:1994;5320-5324.
50. Stott F. J., Bates S., James M. C., McConnell B. B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K. H., Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
51. Tan X., Wang J. Y. J. The caspase-RB connection in cell death. Trends Cell Biol. 8:1998;116-120.
52. Tang H. Y., Zhao K. Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. J. Biol. Chem. 273:1998;29156-29163.
53. Thomas J. T., Laimins L. A. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J. Virol. 72:1998;1131-1137.
54. Vousden K. H., Vojtesek B., Fisher C., Lane D. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53. Oncogene. 8:1993;1697-1702.
55. Wang Y., Okan I., Pokrovskaja K., Wiman K. G. Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis. Oncogene. 12:1996;2731-2735.
56. Wazer D. E., Liu X. L., Chu Q., Gao Q., Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc. Natl. Acad. Sci. USA. 92:1995;3687-3691.
57. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
58. Weinberg R. A. The cat and mouse games that genes, viruses, and cells play. Cell. 88:1997;573-575.
59. White A. E., Livanos E. M., Tlsty T. D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8:1994;666-677.
60. Zhang Y., Xiong Y., Yarbrough W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:1998;725-734.
61. Zhu L., Harlow E., Dynlacht B. D. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1995;1740-1752.
62. zur Hausen H. Papillomavirus infections - A major cause of human cancers. Biochim. Biophys. Acta. 1288:1996;F55-F78.
63. Zindy F., Eischen C. M., Randle D. H., Kamijo T., Cleveland J. L., Sherr C. J., Roussel M. F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:1998;2424-2433.